Trial Profile
A Non-randomized, Single-armed Clinical trial study to determine the therapeutic efficacy of Pegfilgrastim (CinnaGen Company) to treatment of anemia consequent taxans chemotherapy in breast cancer patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Apr 2017
Price :
$35
*
At a glance
- Drugs Pegfilgrastim (Primary)
- Indications Neutropenia
- Focus Therapeutic Use
- Sponsors CinnaGen
- 13 Apr 2017 New trial record